Abstract: To improve antiviral management and understand whether clinically identified
neuraminidase (
NA) inhibitor (
NAI) resistance-associated markers affect influenza B viruses of the Victoria- or Yamagata-lineages differentially, we generated a panel of
NAI-resistant viruses (carrying
E105K,
G145E,
R150K,
D197N,
I221 L/N/T/V,
H273Y,
N294S, or
G407S substitutions; B numbering) in B/Brisbane/60/2008 (BR/08) and B/Phuket/3073/2013 (PH/13).